ROCURONIUM BROMIDE
- Product NDC
- 51662-1354
- 11-digit product format
- 516621354
- Labeler code
- 51662
- Product ID
- 51662-1354_100db255-132c-7c4f-e063-6294a90a01fc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ROCURONIUM BROMIDE
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Application
- ANDA078519
- Marketing category
- ANDA
- Marketing start
- 2019-02-08
- Substance
- ROCURONIUM BROMIDE
- Active strength
- 10 mg/mL
- Pharmacologic classes
- Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ROCURONIUM BROMIDE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ROCURONIUM BROMIDE | 10 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | I65MW4OFHZ |
| Rxcui | 1234995 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51662-1354-1 | ROCURONIUM BROMIDE | 5 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 5 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51662-1354 | ROCURONIUM BROMIDE INJECTION, SOLUTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST] | 5 | Current NDC, Legacy NDC, 1 package rows | 20240130_81628de9-e6bf-8f69-e053-2991aa0a6023.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51662-1354-1 | 51662135401 | 5 mL in 1 VIAL, MULTI-DOSE (51662-1354-1) | 5 ml | 2019-02-08 | 0000-00-00 | No | No | Current |